Lsb Industries, Inc. Liquidation Value

LSB Industries (LXU) is a nitrogen-based chemical manufacturer (ammonia, UAN, AN/nitric acid) with a balance sheet that, under a liquidation lens, produces a deeply negative equity recovery. MFFAIS CLV is reported at -$566M, LLV at -$514M, OLV at -$490M, consistent with the structural asymmetry this filing confirms.

As of March 31, 2026, total assets are $1.19B against total liabilities implied at approximately $648M (book equity $543M). The liquidation problem is concentrated in PP&E: net book value is $826M, but at a 50-70% recovery haircut, realizable value is $413-$578M — the largest single driver of recovery erosion. Cash and short-term investments combined total $182M at near-par recovery. AR of $53M gross (less $363K allowance) recovers at 90-95%, or roughly $50M. Inventory of $23M at 60% yields roughly $14M. Supplies ($34M on balance sheet) are likely site-specific and illiquid; recovery near zero in wind-down.

On the liability side, the $438.6M Senior Secured Notes due October 2028 sit at face value with no change QoQ — the debt was partially repurchased in Q2 and Q4 2025 and has been stable at this level since year-end 2025. Finance lease obligations are $6.0M. Operating lease liabilities total $43.5M ($7.7M current, $35.8M noncurrent) — these obligations do not extinguish on wind-down and must be carried at face value in a liquidation analysis. Deferred tax liability of $67.1M stays at face. Accrued and other current liabilities total approximately $35M. Total current liabilities are $105M.

A material forward-looking commitment: $156.2M of remaining performance obligations (revenue backlog) disclosed in the filing. These represent customer contracts already entered into; in a liquidation, these may constitute obligations to deliver product or refund advances, increasing effective liability exposure. The filing does not separately tag this as a balance-sheet liability, so it is noted here.

QoQ, the balance sheet shows $33M increase in short-term investments (from $129M to $161M), reflecting strong Q1 2026 operating cash flow of $51.8M. PP&E is essentially flat — $17M capex in Q1 offset by depreciation of $20.9M. Long-term debt and equity are effectively unchanged versus December 31, 2025. The valuation allowance on deferred tax assets decreased QoQ (from prior year $14.3M at year-end 2025 to $7.7M at March 31, 2026), reflecting a state VA release that produced the $2.1M income tax benefit in Q1 2026.

Net conclusion: recovery to equity in a stop-and-liquidate scenario is substantially negative. The $438.6M senior secured note principal alone, absent any premium on the PP&E asset base, consumes effectively all tangible liquidation proceeds after satisfying operating lease, current, and other liabilities. The filing discusses environmental compliance obligations ($1.5M incurred Q1 2026; $4-4.4M expected for remainder of 2026) and a $10.2M surety bond indemnification exposure — neither is separately XBRL-tagged as a balance-sheet reserve, but both represent incremental wind-down costs.